Attached files

file filename
EX-16.1 - China Domestica Bio-technology Holdings, Inc.v208008_ex16-1.htm
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
Date of Report (Date of Earliest event Reported): January 11, 2011
 
China Domestica Bio-Technology Holdings, Inc.
(Exact name of registrant as specified in its charter)
 
Nevada
000-53364
20-5432794
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(IRS Employer Identification No.)


Room 2303, 2304 ShenFang Square, 3005 RenMing
Road South, LuFung District, Shenzhen, China

(Address of principal executive offices)

Telephone – (86) 13168096855
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
 
o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
 
o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
 
 
 

 
 

(a)           Dismissal of independent registered public accounting firm

On January 11, 2011, the Board of Directors of China Domestica Bio-Technology Holdings, Inc., a Nevada corporation (the “Company”), dismissed Seale & Beers, CPAs, Las Vegas, Nevada (“Seale & Beers”), as the Company’s independent registered public accounting firm.

The report of Seale and Beers on the Company’s financial statements as of and for the years ended March 31, 2010 and 2009 contained no adverse opinion or disclaimer of opinion nor was qualified or modified as to uncertainty, audit scope, or accounting principle other than the following: the report of Seale & Beers dated August 31, 2010 on our financial statements in the Form 10-K for the fiscal year ended March 31, 2010 contained an explanatory paragraph which noted that there was substantial doubt as to our ability to continue as a going concern.

During the recent fiscal years ending March 31, 2010 and 2009 and through the date of this Current Report, there have been no (i) disagreements with Seale & Beers on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements, if not resolved to Seale & Beers’ satisfaction, would have caused Seale & Beers to make reference to the subject matter of the disagreement(s) in connection with its reports; or (ii) “reportable events” as defined in Item 304(a)(1)(v) of Regulation S-K.

The Company has provided Seale & Beers with a copy of the above disclosures and requested that Seale & Beers furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statement. A copy of Seale & Beers’ letter, dated January 12, 2011 is filed as Exhibit 16.1 to this Current Report on Form 8-K.

(b)           New independent registered public accounting firm

On January 11, 2011, the Board of Directors of Company approved the engagement of Stan H. Lee, CPA (“Lee”), as the Company’s new independent registered public accounting firm.

During the recent fiscal years ending March 31, 2010 and 2009, and through the date of this Current Report, the Company has not consulted Lee regarding (i) the application of accounting principles to any specified transaction, either completed or proposed, (ii) the type of audit opinion that might be rendered on the Company’s financial statements, or (iii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv)) or a reportable event (as defined in Item 304(a)(1)(v)).
 
 
(d)   Exhibits

Exhibit No.
 
Description
16.1
 
Letter of Seale & Beers, CPAs, dated January 12, 2011

 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:
January 11, 2011
 
     
     
   
China Domestica Bio-Technology Holdings, Inc.
   
(Registrant)
     
     
   
/s/ Qingyu Meng
   
*Signature
     
   
President
   
Title